4
million € sales
170 k
people impacted
partnerships with world class players
5
Portfolio Highlights
Target
We bring our expertise to carefully selected investment sectors, developing the industry's future and redefining what is possible.
01
Cutting-edge services including AI-based Discovery, Decentralized Clinical Trials, innovative CDMO solutions like Cell & Gene Therapy, and pioneering Digital Therapeutics.
AI in drug discovery / Decentralised trials
02
We focus on transformative investments in healthcare, encompassing Acute Care in hospitals, Treatment Initiation & Observance, Chronic Treatment innovations, and initiatives for Quality Aging, aiming to elevate patient care and outcomes across all stages of life.
Acute care, Chronic care
03
Our investment strategy targets the forefront of medical technology, including AI-based diagnostics, advanced AI imaging, Digital MedTech innovations, and the pioneering field of Predictive Medicine, all designed to revolutionize patient care and health outcomes.
AI imaging, Digital MedTech
-
Applied prevention | 20% of people under 20
-
Fertility | 40% of couple soon in need of assisted procreation
-
Chronic patients treatment support | 70% of diseases are chronic
-
Neurologic disease treatment | 20% above 65
-
Quality aging | 25% of population by 2040
01
Entrepreneurs
-
Invest in teams aligned with our vision and purpose
-
Foster a movement rooted in our respective countries
-
Aim to scale operations across Europe
02
AI4all
-
Advocate for spreading new models through widespread access to AI, tech knowledge, and STEM studies
-
Fund scholarships and enable student access to the ecosystem
03
Diversity
-
Value diversity among entrepreneurs and startups for enhanced growth
-
Commit to maintaining gender balance in investment decisions
04
Investor Persona
-
Share a vision for healthcare innovation that revolutionises current models
-
Support entrepreneurs that invent rather than optimise
Founders
Laurent
Van Lerberghe
Dr. Sandrine
Van Lerberghe
MBA Insead, Commercial Engineer
Former Chief Strategy Officer Sanofi
& VP Commercial Abbott
Healthcare C-Suite Executive
Investor in Digital Health